Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical trials and tribulations.

Gordon T McInnes1

  • 1University of Glasgow, Department of Medicine and Therapeutics, Western Infirmary, Glasgow, UK. gordon.t.mcinnes@clinmed.gla.ac.uk

Clinical and Experimental Pharmacology & Physiology
|October 9, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies.

The lancet. Diabetes & endocrinology·2018
Same author

Contrasting mortality risks among subgroups of treated hypertensive patients developing new-onset diabetes.

European heart journal·2015
Same author

Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort.

Hypertension (Dallas, Tex. : 1979)·2015
Same author

Response to Effect of serum chloride on mortality in hypertensive patients.

Hypertension (Dallas, Tex. : 1979)·2014
Same author

Serum chloride is an independent predictor of mortality in hypertensive patients.

Hypertension (Dallas, Tex. : 1979)·2013
Same author

Long-term and ultra long-term blood pressure variability during follow-up and mortality in 14,522 patients with hypertension.

Hypertension (Dallas, Tex. : 1979)·2013
Same journal

Relationship Between Long-Term Exposure to Airborne Particulate Matter and the Intrinsic Capacity of Middle-Aged and Older Adults in China: A Retrospective Cohort Study Based on CHARLS.

Clinical and experimental pharmacology & physiology·2026
Same journal

Dapagliflozin Improves Mitochondrial Function to Reduce the Risk of Atrial Fibrillation in a High-Glucose Environment by Activating the AMPK/PGC-1α/SIRT3 Signalling Pathway.

Clinical and experimental pharmacology & physiology·2026
Same journal

Hypertension-Mediated Organ Damage: Pathophysiological Mechanisms, Clinical Consequences, and Implications for Early Risk Stratification.

Clinical and experimental pharmacology & physiology·2026
Same journal

Saikosaponin D Alleviates Atherosclerosis by Regulating Autophagy and Senescence of VSMCs via Inhibiting EPHB2.

Clinical and experimental pharmacology & physiology·2026
Same journal

Noninvasively Evaluating the Cerebral Blood Flow Changes After Surgery in Adult Moyamoya Patients Using 3D Pulsed Arterial Spin Labelling MRI.

Clinical and experimental pharmacology & physiology·2026
Same journal

Targeting S100A8/A9 Ameliorates Heart Failure with Preserved Ejection Fraction by Modulating TLR4/NF-κB-Mediated Inflammation.

Clinical and experimental pharmacology & physiology·2026
See all related articles

Pharmacoepidemiology can reveal differences in hypertension drug outcomes. Angiotensin-converting enzyme inhibitors show a mortality advantage, while calcium channel blockers are linked to poorer prognosis, findings supported by long-term studies.

Area of Science:

  • Clinical Pharmacology
  • Pharmacoepidemiology
  • Cardiovascular Medicine

Background:

  • Hypertension treatment relies on strong evidence, but large trials show stroke prevention but not coronary heart disease event reduction.
  • Newer antihypertensives theoretically offer benefits beyond blood pressure reduction, yet trials with ACE inhibitors and CCBs are inconclusive.
  • Clinical pharmacologists' involvement is crucial throughout drug development, including clinical utility assessment.

Purpose of the Study:

  • To illustrate how pharmacoepidemiology can evaluate the clinical potential of different hypertension drugs.
  • To explore outcome differences between antihypertensive agents using observational data.
  • To highlight the role of clinical pharmacologists in pharmacoepidemiology study design and interpretation.

Main Methods:

Related Experiment Videos

  • Utilizing pharmacoepidemiological principles to analyze outcomes in treated hypertensive patients.
  • Examining the Glasgow Blood Pressure Clinic database for drug-associated outcomes.
  • Conducting preliminary analyses on a primary care database to support findings.

Main Results:

  • Evidence suggests outcome differences between antihypertensive agents.
  • Angiotensin-converting enzyme inhibitor treatment is associated with a mortality advantage.
  • Calcium channel blocker therapy is linked to a poorer prognosis.

Conclusions:

  • Long-term follow-up of high-risk populations can detect outcome differences missed in short-term trials.
  • Pharmacoepidemiology offers a valuable approach to assessing clinical utility of hypertension medications.
  • Understanding observational data strengths and limitations is key for accurate interpretation by clinical pharmacologists.